Time to Load Up-Resistance Training Can Improve the Health of Women with Polycystic Ovary Syndrome (PCOS): A Scoping Review

Chris Kite, Elizabeth Parkes, Suzan R Taylor, Robert W Davies, Lukasz Lagojda, James E Brown, David R Broom, Ioannis Kyrou, Harpal S Randeva, Chris Kite, Elizabeth Parkes, Suzan R Taylor, Robert W Davies, Lukasz Lagojda, James E Brown, David R Broom, Ioannis Kyrou, Harpal S Randeva

Abstract

Background: Guidelines for the management of polycystic ovary syndrome (PCOS) focus on lifestyle changes, incorporating exercise. Whilst evidence suggests that aerobic exercise may be beneficial, less is known about the effectiveness of resistance training (RT), which may be more feasible for those that have low fitness levels and/or are unable to tolerate/participate in aerobic exercise.

Objectives: To identify the available evidence on RT in women with PCOS and to summarise findings in the context of a scoping review.

Eligibility criteria: Studies utilising pre-post designs to assess the effectiveness of RT in PCOS; all outcomes were included.

Sources of evidence: Four databases (PubMed, CENTRAL, CINAHL and SportDiscus) were searched and supplemented by hand searching of relevant papers/reference lists.

Charting methods: Extracted data were presented in tables and qualitatively synthesised.

Results: Searches returned 42 papers; of those, 12 papers were included, relating to six studies/trials. Statistical changes were reported for multiple pertinent outcomes relating to metabolic (i.e., glycaemia and fat-free mass) and hormonal (i.e., testosterone and sex hormone-binding globulin) profiles.

Conclusions: There is a striking lack of studies in this field and, despite the reported statistical significance for many outcomes, the documented magnitude of changes are small and the quality of the evidence questionable. This highlights an unmet need for rigorously designed/reported and sufficiently powered trials.

Keywords: hormones; lifestyle; metabolism; quality of life; strength training; women’s health.

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flow diagram of database searches and study screening.

References

    1. Boyle J.A., Cunningham J., OˈDea K., Dunbar T., Norman R.J. Prevalence of polycystic ovary syndrome in a sample of Indigenous women in Darwin, Australia. Med. J. Aust. 2012;196:62–66. doi: 10.5694/mja11.10553.
    1. Kyrou I., Weickert M.O., Randeva H.S. Endocrinology and Diabetes. Springer; London, UK: 2015. Diagnosis and management of polycystic ovary syndrome (PCOS) pp. 99–113.
    1. Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil. Steril. 2004;81:19–25. doi: 10.1016/j.fertnstert.2003.10.004.
    1. Lim S., Davies M., Norman R., Moran L. Overweight, obesity and central obesity in women with polycystic ovary syndrome: A systematic review and meta-analysis. Hum. Reprod. Update. 2012;18:618–637. doi: 10.1093/humupd/dms030.
    1. Stepto N., Cassar S., Joham A.E., Hutchison S.K., Harrison C.L., Goldstein R.F., Teede H.J. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic–hyperinsulaemic clamp. Hum. Reprod. 2013;28:777–784. doi: 10.1093/humrep/des463.
    1. Kyrou I., Randeva H.S., Tsigos C., Kaltsas G., Weickert M.O. Clinical Problems Caused by Obesity, in Endotext [Internet] MDText. com, Inc.; South Dartmouth, MA, USA: 2018.
    1. Randeva H.S., Tan B.K., Weickert M.O., Lois K., Nestler J.E., Sattar N., Lehnert H. Cardiometabolic aspects of the polycystic ovary syndrome. Endocr. Rev. 2012;33:812–841. doi: 10.1210/er.2012-1003.
    1. Kahal H., Kyrou I., Uthman O.A., Brown A., Johnson S., Wall P.D., Metcalfe A., Parr D.G., Tahrani A.A., Randeva H.S. The prevalence of obstructive sleep apnoea in women with polycystic ovary syndrome: A systematic review and meta-analysis. Sleep Breath. 2020;24:339–350. doi: 10.1007/s11325-019-01835-1.
    1. Moran L.J., Misso M.L., Wild R.A., Norman R. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: A systematic review and meta-analysis. Hum. Reprod. Update. 2010;16:347–363. doi: 10.1093/humupd/dmq001.
    1. Barry J.A., Kuczmierczyk A.R., Hardiman P.J. Anxiety and depression in polycystic ovary syndrome: A systematic review and meta-analysis. Hum. Reprod. 2011;26:2442–2451. doi: 10.1093/humrep/der197.
    1. Karjula S., Morin-Papunen L., Auvinen J., Ruokonen A., Puukka K., Franks S., Järvelin M.-R., Tapanainen J.S., Jokelainen J., Miettunen J. Psychological distress is more prevalent in fertile age and premenopausal women with PCOS symptoms: 15-year follow-up. J. Clin. Endocrinol. Metab. 2017;102:1861–1869. doi: 10.1210/jc.2016-3863.
    1. Tay C.T., Teede H.J., Hill B., Loxton D., Joham A.E. Increased prevalence of eating disorders, low self-esteem, and psychological distress in women with polycystic ovary syndrome: A community-based cohort study. Fertil. Steril. 2019;112:353–361. doi: 10.1016/j.fertnstert.2019.03.027.
    1. Teede H., Deeks A., Moran L. Polycystic ovary syndrome: A complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010;8:41. doi: 10.1186/1741-7015-8-41.
    1. Kite C., Atkinson L., McGregor G., Clark C.C., Brown J.E., Kyrou I., Randeva H.S. Sleep disruption and depression, stress and anxiety levels in women with polycystic ovary syndrome (PCOS) during the lockdown measures for COVID-19 in the UK. Front. Glob. Women’s Health. 2021;2:649104. doi: 10.3389/fgwh.2021.649104.
    1. Jedel E., Waern M., Gustafson D., Landen M., Eriksson E., Holm G., Nilsson L., Lind A.-K., Janson P., Stener-Victorin E. Anxiety and depression symptoms in women with polycystic ovary syndrome compared with controls matched for body mass index. Hum. Reprod. 2010;25:450–456. doi: 10.1093/humrep/dep384.
    1. Podfigurna-Stopa A., Luisi S., Regini C., Katulski K., Centini G., Meczekalski B., Petraglia F. Mood disorders and quality of life in polycystic ovary syndrome. Gynecol. Endocrinol. 2015;31:431–434. doi: 10.3109/09513590.2015.1009437.
    1. Teede H.J., Misso M.L., Costello M.F., Dokras A., Laven J., Moran L., Piltonen T., Norman R.J. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum. Reprod. 2018;33:1602–1618. doi: 10.1093/humrep/dey256.
    1. Pirotta S., Joham A.J., Moran L.J., Skouteris H., Lim S.S. Implementation of evidence-based PCOS lifestyle management guidelines: Perceived barriers and facilitators by consumers using the Theoretical Domains Framework and COM-B Model. Patient Educ. Couns. 2021;104:2080–2088. doi: 10.1016/j.pec.2021.01.036.
    1. Paffenbarger R.S., Jr., Hyde R., Wing A.L., Hsieh C.-C. Physical activity, all-cause mortality, and longevity of college alumni. N. Engl. J. Med. 1986;314:605–613. doi: 10.1056/NEJM198603063141003.
    1. Ekelund U., Ward H.A., Norat T., Luan J.a., May A.M., Weiderpass E., Sharp S.J., Overvad K., Østergaard J.N., Tjønneland A. Physical activity and all-cause mortality across levels of overall and abdominal adiposity in European men and women: The European Prospective Investigation into Cancer and Nutrition Study (EPIC) Am. J. Clin. Nutr. 2015;101:613–621. doi: 10.3945/ajcn.114.100065.
    1. Arem H., Moore S.C., Patel A., Hartge P., De Gonzalez A.B., Visvanathan K., Campbell P.T., Freedman M., Weiderpass E., Adami H.O. Leisure time physical activity and mortality: A detailed pooled analysis of the dose-response relationship. JAMA Intern. Med. 2015;175:959–967. doi: 10.1001/jamainternmed.2015.0533.
    1. Kite C., Lahart I.M., Afzal I., Broom D.R., Randeva H., Kyrou I., Brown J.E. Exercise, or exercise and diet for the management of polycystic ovary syndrome: A systematic review and meta-analysis. Syst. Rev. 2019;8:51. doi: 10.1186/s13643-019-0962-3.
    1. Hultcrantz M., Rind D., Akl E.A., Treweek S., Mustafa R.A., Iorio A., Alper B.S., Meerpohl J.J., Murad M.H., Ansari M.T. The GRADE Working Group clarifies the construct of certainty of evidence. J. Clin. Epidemiol. 2017;87:4–13. doi: 10.1016/j.jclinepi.2017.05.006.
    1. Almenning I., Rieber-Mohn A., Lundgren K.M., Shetelig Løvvik T., Garnæs K.K., Moholdt T. Effects of High Intensity Interval Training and Strength Training on Metabolic, Cardiovascular and Hormonal Outcomes in Women with Polycystic Ovary Syndrome: A Pilot Study. PLoS ONE. 2015;10:e0138793. doi: 10.1371/journal.pone.0138793.
    1. Saremi A., Yaghoubi M.S. Effect of resistance exercises with calcium consumption on level of anti-mullerian hormone and some metabolic indices in women with polycystic ovarian syndrome. Iran. J. Obstet. Gynecol. Infertil. 2016;18:7–15.
    1. Vizza L., Smith C.A., Swaraj S., Agho K., Cheema B.S. The feasibility of progressive resistance training in women with polycystic ovary syndrome: A pilot randomized controlled trial. BMC Sports Sci. Med. Rehabil. 2016;8:14. doi: 10.1186/s13102-016-0039-8.
    1. Piercy K.L., Troiano R.P., Ballard R.M., Carlson S.A., Fulton J.E., Galuska D.A., George S.M., Olson R.D. The physical activity guidelines for Americans. JAMA. 2018;320:2020–2028. doi: 10.1001/jama.2018.14854.
    1. Bull F.C., Al-Ansari S.S., Biddle S., Borodulin K., Buman M.P., Cardon G., Carty C., Chaput J.-P., Chastin S., Chou R. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br. J. Sports Med. 2020;54:1451–1462. doi: 10.1136/bjsports-2020-102955.
    1. Gibson-Moore H. UK Chief Medical Officers’ physical activity guidelines 2019: What’s new and how can we get people more active? Nutr. Bull. 2019;44:320–328. doi: 10.1111/nbu.12409.
    1. Ross R., Chaput J.-P., Giangregorio L.M., Janssen I., Saunders T.J., Kho M.E., Poitras V.J., Tomasone J.R., El-Kotob R., McLaughlin E.C. Canadian 24-Hour Movement Guidelines for Adults aged 18–64 years and Adults aged 65 years or older: An integration of physical activity, sedentary behaviour, and sleep. Appl. Physiol. Nutr. Metab. 2020;45:S57–S102. doi: 10.1139/apnm-2020-0467.
    1. El-Kotob R., Ponzano M., Chaput J.-P., Janssen I., Kho M.E., Poitras V.J., Ross R., Ross-White A., Saunders T.J., Giangregorio L.M. Resistance training and health in adults: An overview of systematic reviews. Appl. Physiol. Nutr. Metab. 2020;45:S165–S179. doi: 10.1139/apnm-2020-0245.
    1. Gordon B., Benson A., Bird S., Fraser S. Resistance training improves metabolic health in type 2 diabetes: A systematic review. Diabetes Res. Clin. Pract. 2009;83:157–175. doi: 10.1016/j.diabres.2008.11.024.
    1. Rhodes R.E., Lubans D.R., Karunamuni N., Kennedy S., Plotnikoff R. Factors associated with participation in resistance training: A systematic review. Br. J. Sports Med. 2017;51:1466–1472. doi: 10.1136/bjsports-2016-096950.
    1. Carneiro L., Afonso J., Ramirez-Campillo R., Murawska-Ciałowciz E., Marques A., Clemente F.M. The effects of exclusively resistance training-based supervised programs in people with depression: A systematic review and meta-analysis of randomized controlled trials. Int. J. Environ. Res. Public Health. 2020;17:6715. doi: 10.3390/ijerph17186715.
    1. Kovacevic A., Mavros Y., Heisz J.J., Singh M.A.F. The effect of resistance exercise on sleep: A systematic review of randomized controlled trials. Sleep Med. Rev. 2018;39:52–68. doi: 10.1016/j.smrv.2017.07.002.
    1. Lopez P., Taaffe D.R., Galvão D.A., Newton R.U., Nonemacher E.R., Wendt V.M., Bassanesi R.N., Turella D.J., Rech A. Resistance training effectiveness on body composition and body weight outcomes in individuals with overweight and obesity across the lifespan: A systematic review and meta-analysis. Obes. Rev. 2022;23:e13428. doi: 10.1111/obr.13428.
    1. Hashida R., Kawaguchi T., Bekki M., Omoto M., Matsuse H., Nago T., Takano Y., Ueno T., Koga H., George J. Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review. J. Hepatol. 2017;66:142–152. doi: 10.1016/j.jhep.2016.08.023.
    1. Donà S., Bacchi E., Moghetti P. Is cardiorespiratory fitness impaired in PCOS women? A review of the literature. J. Endocrinol. Investig. 2017;40:463–469. doi: 10.1007/s40618-016-0599-1.
    1. Tricco A.C., Lillie E., Zarin W., O’Brien K.K., Colquhoun H., Levac D., Moher D., Peters M.D., Horsley T., Weeks L. PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Ann. Intern. Med. 2018;169:467–473. doi: 10.7326/M18-0850.
    1. Lloyd R.S., Faigenbaum A.D. Age- and Sex-Related Differences and Their Implications for Resistance Exercise. In: Haff G.G., Triplett N.T., editors. Essentials of Strength Training and Conditioning. Human Kinetics; Champaign, IL, USA: 2016. pp. 135–154.
    1. Arksey H., O’Malley L. Scoping studies: Towards a methodological framework. Int. J. Soc. Res. Methodol. 2005;8:19–32. doi: 10.1080/1364557032000119616.
    1. Ramos F.K.P., Lara L.A.D.S., Kogure G.S., Silva R.C., Ferriani R.A., Silva de Sá M.F., Reis R.M.D. Quality of life in women with polycystic ovary syndrome after a program of resistance exercise training. Rev. Bras. Ginecol. E Obs. 2016;38:340–347. doi: 10.1055/s-0036-1585457.
    1. Kogure G.S., Miranda-Furtado C.L., Pedroso D.C.C., Ribeiro V.B., Eiras M.C., Silva R.C., Caetano L.C., Ferriani R.A., Calado R.T., Dos Reis R.M. Effects of Progressive Resistance Training on Obesity Indices in Polycystic Ovary Syndrome and the Relationship With Telomere Length. J. Phys. Act. Health. 2019;16:601–607. doi: 10.1123/jpah.2018-0256.
    1. Kogure G.S., Miranda-Furtado C.L., Silva R.C., Melo A.S., Ferriani R.A., De Sá M.F., Dos Reis R.M. Resistance Exercise Impacts Lean Muscle Mass in Women with Polycystic Ovary Syndrome. Med. Sci. Sports Exerc. 2016;48:589–598. doi: 10.1249/MSS.0000000000000822.
    1. Kogure G.S., Silva R.C., Miranda-Furtado C.L., Ribeiro V.B., Pedroso D.C.C., Melo A.S., Ferriani R.A., Reis R.M.D. Hyperandrogenism Enhances Muscle Strength after Progressive Resistance Training, Independent of Body Composition, in Women with Polycystic Ovary Syndrome. J. Strength Cond. Res. 2018;32:2642–2651. doi: 10.1519/JSC.0000000000002714.
    1. Miranda-Furtado C.L., Ramos F.K., Kogure G.S., Santana-Lemos B.A., Ferriani R.A., Calado R.T., Dos Reis R.M. A Nonrandomized Trial of Progressive Resistance Training Intervention in Women With Polycystic Ovary Syndrome and Its Implications in Telomere Content. Reprod. Sci. 2016;23:644–654. doi: 10.1177/1933719115611753.
    1. Ribeiro V.B., Kogure G.S., Reis R.M., Gastaldi A.C., De AraÚJo J.E., Mazon J.H., Borghi A., Souza H.C.D. Polycystic Ovary Syndrome Presents Higher Sympathetic Cardiac Autonomic Modulation that is not altered by Strength Training. Int. J. Exerc. Sci. 2016;9:554–566.
    1. Lara L.A., Ramos F.K., Kogure G.S., Costa R.S., Silva de Sá M.F., Ferriani R.A., dos Reis R.M. Impact of Physical Resistance Training on the Sexual Function of Women with Polycystic Ovary Syndrome. J. Sex. Med. 2015;12:1584–1590. doi: 10.1111/jsm.12909.
    1. Rao M., Khan A.A., Adnan Q.U.A. Effects of high-intensity interval training and strength training on levels of testosterone and physical activity among women with polycystic ovary syndrome. Obstet. Gynecol. Sci. 2022 doi: 10.5468/ogs.22002.
    1. Hosseini S.A., Kazemi N., Shadmehri S., Jalili S., Ahmadi M. The effect of resistance training in water and land with vitamin D supplementation on anti-mullerian hormone in women with polycystic ovary syndrome. Women’s Health Bull. 2019;6:1–6. doi: 10.5812/whb.84882.
    1. Freiman J.A., Chalmers T.C., Smith H.A., Kuebler R.R. Medical Uses of Statistics. CRC Press; Boca Raton, FL, USA: 2019. The importance of beta, the type II error, and sample size in the design and interpretation of the randomized controlled trial: Survey of two sets of “negative” trials; pp. 357–389.
    1. Wallace S.S., Barak G., Truong G., Parker M.W. Hierarchy of Evidence Within the Medical Literature. Hosp. Pediatrics. 2022;12:745–750. doi: 10.1542/hpeds.2022-006690.
    1. Katsukawa F. FITT principle of exercise in the management of lifestyle-related diseases. Clin. Calcium. 2016;26:447–451.
    1. Smidt N., de Vet H.C., Bouter L.M., Dekker J. Effectiveness of exercise therapy: A best-evidence summary of systematic reviews. Aust. J. Physiother. 2005;51:71–85. doi: 10.1016/S0004-9514(05)70036-2.
    1. McLean S., Holden M.A., Potia T., Gee M., Mallett R., Bhanbhro S., Parsons H., Haywood K. Quality and acceptability of measures of exercise adherence in musculoskeletal settings: A systematic review. Rheumatology. 2017;56:426–438. doi: 10.1093/rheumatology/kew422.
    1. Courneya K.S., Forbes C.C., Trinh L., Sellar C.M., Friedenreich C.M., Reiman T. Patient satisfaction with participation in a randomized exercise trial: Effects of randomization and a usual care posttrial exercise program. Clin. Trials. 2013;10:959–966. doi: 10.1177/1740774513495985.
    1. Hertogh E.M., Schuit A.J., Peeters P.H., Monninkhof E.M. Noncompliance in lifestyle intervention studies: The instrumental variable method provides insight into the bias. J. Clin. Epidemiol. 2010;63:900–906. doi: 10.1016/j.jclinepi.2009.10.007.
    1. Steins Bisschop C.N., Courneya K.S., Velthuis M.J., Monninkhof E.M., Jones L.W., Friedenreich C., Van Der Wall E., Peeters P.H., May A.M. Control group design, contamination and drop-out in exercise oncology trials: A systematic review. PLoS ONE. 2015;10:e0120996. doi: 10.1371/journal.pone.0120996.
    1. McGlothlin A.E., Lewis R.J. Minimal clinically important difference: Defining what really matters to patients. JAMA. 2014;312:1342–1343. doi: 10.1001/jama.2014.13128.
    1. Hinderliter A.L., Sherwood A., Craighead L.W., Lin P.-H., Watkins L., Babyak M.A., Blumenthal J.A. The long-term effects of lifestyle change on blood pressure: One-year follow-up of the ENCORE study. Am. J. Hypertens. 2014;27:734–741. doi: 10.1093/ajh/hpt183.
    1. Petticrew M., Roberts H. Systematic Reviews in the Social Sciences: A Practical Guide. John Wiley & Sons; Hoboken, NJ, USA: 2008.
    1. Higgins J.P., Savović J., Page M.J., Elbers R.G., Sterne J.A. Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration and John Wiley and Sons Ltd.; Chichester, UK: 2019. Assessing risk of bias in a randomized trial; pp. 205–228.
    1. Sterne J.A., Hernán M.A., McAleenan A., Reeves B.C., Higgins J.P. Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration and John Wiley and Sons Ltd.; Chichester, UK: 2019. Assessing risk of bias in a non-randomized study; pp. 621–641.
    1. Slade S.C., Dionne C.E., Underwood M., Buchbinder R. Consensus on exercise reporting template (CERT): Explanation and elaboration statement. Br. J. Sports Med. 2016;50:1428–1437. doi: 10.1136/bjsports-2016-096651.
    1. Guyatt G., Oxman A.D., Akl E.A., Kunz R., Vist G., Brozek J., Norris S., Falck-Ytter Y., Glasziou P., DeBeer H. GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables. J. Clin. Epidemiol. 2011;64:383–394. doi: 10.1016/j.jclinepi.2010.04.026.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera